Delivery Order SPE2DB24D1006-SPE2DB25FCEZL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methazolamide 50 mg tablets (100-count packages) under a firm fixed-price contract valued at $1,195.55. The award was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $15,598.62 on July 10, 2025, for the supply of Methazolamide Continuous Tablets 60mg. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 11, 2025, with fulfillment from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,174.22 to AmerisourceBergen Drug Corp for the supply of Methazolamide 50 mg tablets (100-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and was finalized on July 29, 2025, with a completion deadline of July 30, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,685.76 to AmerisourceBergen Drug Corp for the supply of Methazolamide 50 mg tablets (100 count) on October 22, 2025, with completion expected by October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 25, 2025, valued at $8,633.25 for the supply of Methazolamide Continuous Tablets 30mg to support the Defense Logistics Agency's Medical Supply Chain. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025 and performance location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and is issued as a child contract under...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,231.25 firm fixed-price delivery order is for the supply of 4,568,235,107 units of the medication Methazolamide 50 mg tablets. The award is not set-aside and has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,168.92, is for the supply of 4,564,361,959 units of the pharmaceutical product Methazolamide 50 mg Tablet. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
- This federal contract award, valued at $1,496.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,802,739 units of Methazolamide 50 mg tablets in 100-count bottles, with a performance period ending on September 16, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,549.74, is for the delivery of Methazolamide 50 mg tablets in quantities of 100. It is a firm fixed-price delivery order contract with a completion date of November 29, 2023. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,360,459 units of the pharmaceutical product Methazolamide 25 mg tablets. The contract has a firm fixed price ceiling value of $1,147.26 and an ultimate completion date of April 23, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEZLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methazolamide 50 mg tablets (100-count units) with a contract value of $4,031.07. This competitively awarded, non-set-aside delivery order is classified as a firm fixed-price contract with an ultimate completion date of August 7, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. As a prime contractor for this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its established capability to meet defense medical procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/6/25 |